RECRUITING

Pancreatic Cancer Detection Consortium

Description

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Conditions

Pancreatic CancerPancreatic CarcinomaPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic NeoplasmsPancreatic Cancer Stage IPancreatic Cancer StagePancreatic Cancer ResectablePancreatic Cancer Stage 0Pancreatic Cancer Stage IIPancreatic Cancer Stage IIIPancreatic Cancer, AdultPancreatic Cancer Non-resectable
Talk to us

Related Conditions:

Pancreatic CancerPancreatic CarcinomaPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic NeoplasmsPancreatic Cancer Stage IPancreatic Cancer StagePancreatic Cancer ResectablePancreatic Cancer Stage 0Pancreatic Cancer Stage IIPancreatic Cancer Stage IIIPancreatic Cancer, AdultPancreatic Cancer Non-resectable

Study Overview

On this page

Study Details

Study overview

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Early Detection of Pancreatic Cancer: Prospective Study

Pancreatic Cancer Detection Consortium

Condition
Pancreatic Cancer
Intervention / Treatment

-

Contacts and Locations

Phoenix

Translational Genomics Research Institute, Phoenix, Arizona, United States, 85004

Scottsdale

Honorhealth, Scottsdale, Arizona, United States, 85258

Monrovia

City of Hope Medical Center, Monrovia, California, United States, 91016

Newport Beach

Hoag Center, Newport Beach, California, United States, 92663

Peoria

OSF HealthCare, Peoria, Illinois, United States, 61637

Jefferson

Ochsner Medical Center, Jefferson, Louisiana, United States, 70121

Morristown

Atlantic Health System, Morristown, New Jersey, United States, 07960

Rock Hill

Piedmont Medical Center, Rock Hill, South Carolina, United States, 29732

Milwaukee

Medical College of Wisconsin, Milwaukee, Wisconsin, United States, 53226

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition)
  • * Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.
  • * Imaging- or endoscopy-based proof of lack of pancreatic ductal adenocarcinoma at the time of sampling (Non-disease controls)
  • * Lack of written informed consent.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

City of Hope Medical Center,

Ajay Goel, PhD, PRINCIPAL_INVESTIGATOR, City of Hope Medical Center

Study Record Dates

2025-11-21